Prospective comparison of 18F-PSMA-1007 PET/CT and whole-body MRI/DWI with CT for primary lymph node staging of unfavorable intermediate and high-risk prostate cancer

被引：0
|
作者：
Malaspina, S. [1 ,2 ]
Anttinen, M. [2 ,3 ]
Jambor, I. [4 ]
Sandell, M. [2 ,5 ]
Rinta-Kiikka, I. [6 ]
Kajander, S. [1 ,2 ]
Schildt, J. [7 ]
Saukko, E. [2 ,8 ]
Noponen, T. [2 ,9 ]
Saunavaara, J. [2 ,5 ]
Taimen, P. [10 ,11 ]
Dean, P. B. [2 ,8 ]
Sequeiros, R. B. [2 ,8 ]
Aronen, H. J. [2 ,8 ]
Kemppainen, J. [1 ,2 ]
Seppanen, M. [2 ,12 ]
Bostrom, P. J. [2 ,3 ]
Ettala, O. [2 ,3 ]
机构：
[1] Univ Turku, Turku PET Ctr, Turku, Finland
[2] Turku Univ Hosp, Turku, Finland
[3] Univ Turku, Dept Urol, Turku, Finland
[4] Icahn Sch Med Mt Sinai, Dept Radiol, New York, NY 10029 USA
[5] Univ Turku, Med Imaging Ctr Southwest Finland, Turku, Finland
[6] Tampere Univ Hosp, Dept Radiol, Tampere, Finland
[7] Univ Helsinki, Cent Hosp, Dept Clin Physiol & Nucl Med, Helsinki, Finland
[8] Univ Turku, Dept Diagnost Radiol, Turku, Finland
[9] Univ Turku, Dept Med Phys & Nucl Med, Turku, Finland
[10] Univ Turku, Inst Biomed, Turku, Finland
[11] Turku Univ Hosp, Dept Pathol, Turku, Finland
[12] Univ Turku, Nucl Med, Dept Clin Physiol, Turku, Finland
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2020年 / 47卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-914
引用
收藏
页码：S455 / S455
页数：1
相关论文
共 50 条
  • [1] Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavorable intermediate and high-risk prostate cancer
    Campana, John
    Bernal, Patricia
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (09) : 2670 - 2671
  • [2] Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavorable intermediate and high-risk prostate cancer
    John Campaña
    Patricia Bernal
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 2670 - 2671
  • [3] Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate cancer
    Simona Malaspina
    Mikael Anttinen
    Pekka Taimen
    Ivan Jambor
    Minna Sandell
    Irina Rinta-Kiikka
    Sami Kajander
    Jukka Schildt
    Ekaterina Saukko
    Tommi Noponen
    Jani Saunavaara
    Peter B. Dean
    Roberto Blanco Sequeiros
    Hannu J. Aronen
    Jukka Kemppainen
    Marko Seppänen
    Peter J. Boström
    Otto Ettala
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 2951 - 2959
  • [4] Response to the Letter to the Editor: Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate cancer
    Malaspina, Simona
    Anttinen, Mikael
    Taimen, Pekka
    Loyttyniemi, Eliisa
    Kemppainen, Jukka
    Seppanen, Marko
    Bostrom, Peter
    Ettala, Otto
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (09) : 2672 - 2673
  • [5] Response to the Letter to the Editor: Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate cancer
    Simona Malaspina
    Mikael Anttinen
    Pekka Taimen
    Eliisa Löyttyniemi
    Jukka Kemppainen
    Marko Seppänen
    Peter Boström
    Otto Ettala
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 2672 - 2673
  • [6] Comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and 99mTc-HMDP SPECT/CT to planar bone scintigraphy and CT in primary staging of intermediate or high-risk prostate cancer
    Malaspina, S.
    Anttinen, M.
    Ettala, O.
    Jambor, I.
    Kemppainen, J.
    Sandell, M.
    Rinta-Kiikka, I.
    Kajander, S.
    Schildt, J.
    Saukko, E.
    Timonen, K.
    Rautio, P.
    Noponen, T.
    Saunavaara, J.
    Aronen, H.
    Seppanen, M.
    Bostrom, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S293 - S293
  • [7] PRIMARY METASTASIS STAGING USING 18F-PSMA-1007 PET-CT IN HIGH-RISK PROSTATE CANCER
    Anttinen, Mikael
    Ettala, Otto
    Malaspina, Simona
    Jambor, Ivan
    Sandell, Minna
    Kajander, Sami
    Rinta-Kiikka, Irina
    Schildt, Jukka
    Saukko, Ekaterina
    Rautio, Pentti
    Timonen, Kirsi L.
    Noponen, Tommi
    Saunavaara, Jani
    Loyttyniemi, Eliisa
    Taimen, Pekka
    Kemppainen, Jukka
    Dean, Peter B.
    Blanco, Roberto Sequeiros
    Aronen, Hannu J.
    Seppanen, Marko
    Bostrom, Peter J.
    JOURNAL OF UROLOGY, 2020, 203 : E952 - E952
  • [8] Comparison of 18F-PSMA-1007 PET/CT With 68Ga-PSMA-11 PET/CT for Initial Staging in Intermediate- and High-Risk Prostate Cancer
    Chandekar, Kunal Ramesh
    Singh, Harmandeep
    Kumar, Rajender
    Kumar, Santosh
    Kakkar, Nandita
    Mittal, Bhagwant Rai
    Singh, Shrawan Kumar
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (01) : E1 - E8
  • [9] PSMA-density predicts pathological and oncological outcomes in patients submitted to 18F-PSMA-1007 PET/CT for the primary staging of unfavorable intermediate and high-risk prostate cancer
    Donegani, M.
    Ambrosini, F.
    Mantica, G.
    Piol, N.
    Miceli, A.
    D'Amico, F.
    Riondato, M.
    Di Raimondo, T.
    Lanfranchi, F.
    Raffa, S.
    Chiola, S.
    Spina, B.
    Suardi, N.
    Morbelli, S.
    Borghesi, M.
    Nozza, P.
    Fiocca, R.
    Sambuceti, G.
    Terrone, C.
    Bauckneht, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S218 - S218
  • [10] Diagnostic accuracy of 18F-PSMA-1007 PET/CT in primary staging of intermediate- and high-risk prostate cancer with extended lymph node dissection used as reference method
    Ingvar, J. K. O.
    Hvittfeldt, E.
    Simoulis, A.
    Tragardh, E.
    Bjartell, A. S.
    EUROPEAN UROLOGY, 2022, 81 : S986 - S986
12345